Hyperway Pharm Funding: $54M Raised, Series B (2025)

Hyperway Pharm funding overview

Hyperway Pharm is based in Chengdu, China. Hyperway Pharm has raised $54M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in October 2025. The round record for Hyperway Pharm runs through 2025; nothing later has been disclosed. Investors on record include Orinno Capital, Guoyuan Innovating Investment, Sunbow Capital, Hygeia Capital, WAN LEI, Ziyuan Capital and 1 others. 7 distinct backers are named across the disclosed rounds.

Hyperway Pharm at a glance

Total raised: $54M
Latest round: Series B
Latest round date: October 2025
Headquarters: Chengdu, China
Notable investors: Orinno Capital, Guoyuan Innovating Investment, Sunbow Capital, Hygeia Capital, WAN LEI, Ziyuan Capital, Huagai Capital

Frequently asked about Hyperway Pharm funding

How much has Hyperway Pharm raised?: Hyperway Pharm has raised $54M in total disclosed funding across the rounds on record.
Who has invested in Hyperway Pharm?: Orinno Capital, Guoyuan Innovating Investment, Sunbow Capital, Hygeia Capital, WAN LEI, Ziyuan Capital are named among the investors backing Hyperway Pharm.
What was the latest Hyperway Pharm funding round?: The most recent disclosed round is a Series B, announced in October 2025.
Where is Hyperway Pharm based?: Hyperway Pharm is based in Chengdu, China.
When did Hyperway Pharm last raise?: The last disclosed Hyperway Pharm round closed in October 2025 at Series B.

Hyperway Pharm totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Chengdu below to benchmark round size and investor mix.

Hyperway Pharm Funding: $54M Raised, Series B (2025)

Hyperway Pharm funding overview

Hyperway Pharm at a glance

Frequently asked about Hyperway Pharm funding

Companies related to Hyperway Pharm (19)

Browse related funding lists (3)